First Oral Therapy for Rare Adrenal Gland Tumors Gets Green Light From FDA

(MedPage Today) — The FDA has expanded the approval of belzutifan (Welireg) to include certain types of pheochromocytoma or paraganglioma (PPGL) in adults and children.
The action establishes belzutifan as the only approved oral therapy for PPGL…